SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-335225
Filing Date
2021-11-19
Accepted
2021-11-19 16:32:12
Documents
12
Period of Report
2021-11-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d268656d8k.htm   iXBRL 8-K 22064
  Complete submission text file 0001193125-21-335225.txt   139363

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA advm-20211118.xsd EX-101.SCH 2889
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20211118_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20211118_pre.xml EX-101.PRE 10951
5 EXTRACTED XBRL INSTANCE DOCUMENT d268656d8k_htm.xml XML 3214
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 211428782
SIC: 2836 Biological Products, (No Diagnostic Substances)